Cargando…
Pathoblockers or antivirulence drugs as a new option for the treatment of bacterial infections
The rapid development of antimicrobial resistance is threatening mankind to such an extent that the World Health Organization expects more deaths from infections than from cancer in 2050 if current trends continue. To avoid this scenario, new classes of anti-infectives must urgently be developed. An...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Beilstein-Institut
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204809/ https://www.ncbi.nlm.nih.gov/pubmed/30410623 http://dx.doi.org/10.3762/bjoc.14.239 |